Evolv Technologies Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 10, 2026, reporting condensed consolidated financial results for the third quarter.

Key Highlights

  • Shares outstanding: 181,385,455 shares of Class A common stock, par value $0.0001 per share, were outstanding as of November 5, 2026, according to the filing.
  • Total assets: The company reported total assets of $303,061 thousand as of September 30, 2026, compared with $304,409 thousand as of December 31, 2025.
  • Cash and cash equivalents: Cash and cash equivalents stood at $61,910 thousand as of September 30, 2026, up from $49,150 thousand at December 31, 2025.
  • Current deferred revenue: The current portion of deferred revenue increased to $87,385 thousand from $74,924 thousand at December 31, 2025.
  • Total liabilities: Total liabilities were $195,275 thousand as of September 30, 2026, compared with $184,987 thousand at December 31, 2025.
  • Long-term debt: Long-term debt was reported at $28,811 thousand as of September 30, 2026, versus $28,596 thousand at December 31, 2025.
  • Accounts receivable: Net accounts receivable rose to $50,412 thousand from $30,841 thousand at December 31, 2025, with an allowance for expected credit losses of $750 thousand.

Evolv Technologies Balance Sheet Shifts in Third Quarter 2026

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a Delaware-incorporated company headquartered at 500 Totten Pond Road, Waltham, Massachusetts, filed its quarterly report covering the period ended September 30, 2026. According to the filing, total assets declined modestly to $303,061 thousand from $304,409 thousand at December 31, 2025, while total liabilities grew from $184,987 thousand to $195,275 thousand over the same period.

The filing disclosed that cash and cash equivalents increased to $61,910 thousand from $49,150 thousand at year-end 2025, while marketable securities decreased to $4,951 thousand from $19,885 thousand. Accounts receivable, net of an allowance for expected credit losses of $750 thousand, rose to $50,412 thousand from $30,841 thousand. Inventory declined to $5,793 thousand from $9,317 thousand. Property and equipment, net, was reported at $132,818 thousand, up from $127,522 thousand at December 31, 2025.

On the liabilities side, the filing noted that the current portion of deferred revenue increased to $87,385 thousand from $74,924 thousand, and noncurrent deferred revenue rose to $19,419 thousand from $16,716 thousand. Several liability items that appeared on the December 31, 2025 balance sheet, including a contingent earn-out liability of $374 thousand, a contingently issuable common stock liability of $1,809 thousand, and a public warrant liability of $3,862 thousand, were each reported at zero as of September 30, 2026. The company disclosed that it is a non-accelerated filer and is not an emerging growth company. The filing contains forward-looking statements that are subject to the company's cautionary language as described in Part II, Item 1A of the report.

What Was Disclosed

Evolv Technologies filed a Form 10-Q for the quarter ended September 30, 2026, disclosing condensed consolidated balance sheet data showing total assets of $303,061 thousand, total liabilities of $195,275 thousand, and 181,385,455 shares of Class A common stock outstanding as of November 5, 2026.